熱門資訊> 正文

Alto Neuroscience GAAP EPS—9.73美元

2024-03-22 04:49

Informatica Inc.(NYSE) 0
Alto Neuroscience, Inc.(ANRO) 0

Alto Neuroscience press release (NYSE:ANRO): FY GAAP EPS of -$9.73.
As of December 31, 2023, Alto had cash and cash equivalents of $82.5 million.
The Company expects its cash balance to support planned operations into 2027.

More on Alto Neuroscience

Alto Neuroscience: Potential First-In-Class Approach To Targeting CNS Disorders
Alto Neuroscience Starts IPO Plan For CNS Disorder Treatments

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。